Prime Movers Lab Fund I LP - Nov 15, 2021 Form 4 Insider Report for Vaxxinity, Inc. (VAXX)

Role
10%+ Owner
Signature
Prime Movers Lab Fund I LP /s/ Jon Layman, Authorized Person
Stock symbol
VAXX
Transactions as of
Nov 15, 2021
Transactions value $
$0
Form type
4
Date filed
11/15/2021, 03:24 PM
Previous filing
Nov 10, 2021
Next filing
Feb 18, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VAXX Class A common stock Conversion of derivative security +2.29M 2.29M Nov 15, 2021 Held by COVAXX PML SPV 1 LP F1, F2, F7
transaction VAXX Class A common stock Conversion of derivative security +862K 862K Nov 15, 2021 Held by COVAXX PML SPV 2 LP F1, F3, F7
transaction VAXX Class A common stock Conversion of derivative security +1.52M 1.52M Nov 15, 2021 Held by COVAXX PML SPV 3 LP F1, F4, F7
transaction VAXX Class A common stock Conversion of derivative security +3.62M 3.62M Nov 15, 2021 Held by Prime Movers Growth Fund 1 LP F1, F5, F7
transaction VAXX Class A common stock Conversion of derivative security +9.74M 9.74M Nov 15, 2021 Direct F1, F6, F7

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VAXX Series A preferred stock Conversion of derivative security -3.57M -100% 0 Nov 15, 2021 Class A common stock 2.29M Held by COVAXX PML SPV 1 LP F1, F2, F7
transaction VAXX Series A preferred stock Conversion of derivative security -1.34M -100% 0 Nov 15, 2021 Class A common stock 862K Held by COVAXX PML SPV 2 LP F1, F3, F7
transaction VAXX Series A preferred stock Conversion of derivative security -2.36M -100% 0 Nov 15, 2021 Class A common stock 1.52M Held by COVAXX PML SPV 3 LP F1, F4, F7
transaction VAXX Series B preferred stock Conversion of derivative security -5.63M -100% 0 Nov 15, 2021 Class A common stock 3.62M Held by Prime Movers Growth Fund 1 LP F1, F5, F7
transaction VAXX Series A preferred stock Conversion of derivative security -15.2M -100% 0 Nov 15, 2021 Class A common stock 9.74M Direct F1, F6, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares of preferred stock automatically converted into shares of Class A common stock upon closing of the Issuer's initial public offering based on a conversion rate of approximately 0.643 shares of Class A common stock for each share of preferred stock.
F2 Held by COVAXX PML SPV 1 LP ("PML SPV 1"). Prime Movers Lab GP I LLC ("PML GP I") is the general partner of Prime Movers Lab Fund I LP ("PML") and PML SPV 1.
F3 Held by COVAXX PML SPV 2 LP ("PML SPV 2"). Prime Movers Lab GP II LLC ("PML GP II") is the general partner of PML SPV 2.
F4 Held by COVAXX PML SPV 3 LP ("PML SPV 3"). PML GP II is the general partner of PML SPV 3.
F5 Held by Prime Movers Growth Fund 1 LP ("PMG"). Prime Movers Growth GP I LLC ("PMG GP") is the general partner of PMG.
F6 Held by PML. PML GP I is the general partner of PML.
F7 Dakin Sloss is the manager of PML GP I, PML GP II and PMG GP, and may be deemed to beneficially own the securities held by PML, PMG, PML SPV 1, PML SPV 2 and PML SPV 3. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein.